Jayakumar, Vasanthan
Ishii, Hiromi
Seki, Misato
Kumita, Wakako
Inoue, Takashi
Hase, Sumitaka
Sato, Kengo
Okano, Hideyuki
Sasaki, Erika
Sakakibara, Yasubumi
Funding for this research was provided by:
Japan Society for the Promotion of Science (Kakenhi 16H06279 and 18H04127)
Ministry of Education, Culture, Sports, Science and Technology (Innovative areas 221S0002)
Japan Agency for Medical Research and Development (JP19kk0305008)
Article History
Received: 5 March 2020
Accepted: 9 March 2020
First Online: 2 April 2020
Ethics approval and consent to participate
: The animal experiment protocol was approved by the CIEA Institutional Animal Care and Use Committee (approval nos. 16041 and 17031). Also, all the animal experiments were approved by the Institutional Animal Care and Use Committee (approval nos. 12025 and 13071). The study was conducted in accordance with the guidelines of CIEA that comply with the Guidelines for Proper Conduct of Animal Experiments published by the Science Council of Japan. Animal care was conducted in accordance with the Guide for the Care and Use of Laboratory Animals (Institute for Laboratory Animal Resources, 2011).
: Not applicable.
: H.O is a paid Scientific Advisory Board of SanBio Co. Ltd. And K Pharma Inc. The other authors declare no competing financial interests.